Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 123 citing Emanuel: Chemotherapy use among Medicare beneficiaries at the end of life. (0.12 sec) 

Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon …

- ascopubs.org [PDF] 
Y Wang, T Jatkoe, Y Zhang, MG Mutch, D … - Journal of Clinical Oncology, 2004 - jco.ascopubs.org
Leonard L. Gunderson, Daniel J. Sargent, Joel E. Tepper, Norman Wolmark, Michael
J. O'Connell, Mirsada Begovic, Cristine Allmer, Linda Colangelo, Steven R.
Smalley, Daniel G. Haller, James A. Martenson, Robert J. Mayer, Tyvin A. ...
Cited by 218 - Related articles - BL Direct - All 7 versions

Approaching difficult communication tasks in oncology

- amcancersoc.org
AL Back, RM Arnold, WF Baile, JA Tulsky, K … - CA: A Cancer Journal for Clinicians, 2005 - Am Cancer Soc
Effective communication skills enable physicians to improve patients'
understanding of their illnesses, improve patient adherence to treatment
regimens, use time efficiently, avoid burnout, and increase professional ...
Cited by 101 - Related articles - All 10 versions

High and rising health care costs. Part 4: can costs be controlled while preserving quality?

- ct.gov [PDF] 
T Bodenheimer, A Fernandez - Annals of internal medicine, 2005 - Am Coll Physicians
An example of a cost-reducing, quality-enhancing program is post-hospital nurse
monitoring and intervention for patients at high risk for repeated
hospitalization for congestive heart failure. Disease management programs ...
Cited by 52 - Related articles - BL Direct - All 7 versions

Why do patients choose chemotherapy near the end of life? A review of the perspective of …

- ascopubs.org
R Matsuyama, S Reddy, TJ Smith - Journal of Clinical Oncology, 2006 - jco.ascopubs.org
RESULTS: Available patient sources provide little information about prognosis,
choices, alternatives, consequences, or how to choose. Many patients would
choose chemotherapy for a small benefit in health outcomes, and for a ...
Cited by 46 - Related articles - All 7 versions

Are chemotherapy response rates related to treatment-induced survival prolongations in …

- ascopubs.org
TD Shanafelt, C Loprinzi, R Marks, P Novotny, … - Journal of Clinical Oncology, 2004 - jco.ascopubs.org
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Are Chemotherapy Response Rates Related to Treatment-Induced Survival ...
Cited by 43 - Related articles - BL Direct - All 7 versions

Resurrecting treatment histories of dead patients: a study design that should be laid to rest


PB Bach, D Schrag, CB Begg - JAMA, 2004 - Am Med Assoc
In this article we address whether studies of care rendered to patients prior to
their death ("studies of decedents") produce an accurate portrait of care
provided to patients who are dying. Studies of decedents typically analyze ...
Cited by 43 - Related articles - BL Direct - All 4 versions

Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of- …


C Von Plessen, B Bergman, O Andresen, RM … - British journal of cancer, 2006 - pubmedcentral.nih.gov
This randomised multicentre trial was conducted to establish the optimal
duration of palliative chemotherapy in advanced non-small-cell lung cancer
(NSCLC). We compared a policy of three vs six courses of new-generation ...
Cited by 30 - Related articles - BL Direct - All 4 versions

Sick to death and not going to take it anymore! Reforming health care for the last years of life


RL Kane - JAMA, 2005 - Am Med Assoc
This book is worth reading, not necessarily because you will agree with it or
accept its proposals but because it raises a series of important challenges to
current thinking. Gerontologists calculate age not chronologically but as a ...
Cited by 28 - Related articles - All 9 versions

Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding …

- ascopubs.org [PDF] 
DA Patt, Z Duan, S Fang, GN Hortobagyi, SH … - Journal of Clinical Oncology, 2007 - jco.ascopubs.org
Purpose To evaluate the effect of antifungal prophylaxis on all-cause mortality
as primary outcome, invasive fungal infections (IFIs), and adverse events. Many
studies have evaluated the role of antifungal prophylaxis in cancer ...
Cited by 30 - Related articles - All 4 versions

Hospice admission practices: where does hospice fit in the continuum of care?


KA Lorenz, SM Asch, KE Rosenfeld, H Liu, SL … - Journal of the American Geriatrics Society, 2004 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 28 - Related articles - BL Direct - All 8 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google